Search

everythinglearnresearchcommunity

for

Search:↓

Skin issues are common in lupus patients, highlighting the need for thorough skin checks.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Innate lymphoid cells help us understand and manage allergic diseases better.

Homemade skin products can cause allergic reactions, so use registered products if you have allergies.

Antibiotics often cause skin reactions, making them a major health concern.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Understanding genetic traits can help doctors create personalized detox and nutrition plans to boost antioxidant protection.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

Early detection and skin biopsies are crucial for treating skin cancer and diagnosing various skin conditions.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Combining microneedling with platelet-rich plasma enhances skin repair and collagen production but may not offer significant extra benefits.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

The document lists various dermatology topics, treatments, and diagnostic methods.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Researchers found a new mutation in the EDA gene that likely causes missing teeth and mild skin symptoms in one family.